French National Registry of Bone Marrow Failures
NCT04781790 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2021-03-04
Summary
This is a unique clinical and biological database that collects standardized clinical information during the management of all patients with bone marrow failure syndromes (BMF) in France (multicenter registry), from diagnosis and throughout follow-up during the natural history of the disease, treated or not. In parallel, biological samples (blood and/or bone marrow and/or skin) are collected during clinical care and are biobanked in Saint-Louis Hospital (Hematology laboratory) in order to be used in translational research related to bone marrow failure diseases.
This registry has two main objectives:
* Public health care evaluation and improvement: to assess the medical and social needs inherent to the management of these rare diseases; to precisely assess the level of diagnosis and management of bone marrow failure syndromes in France; to evaluate the impact and guidance of the French reference center guidelines for diagnosis and treatment; to evaluate the real-life efficacy and tolerance of any given specific treatments; to analyze treatment's cost-effectiveness according to each situation.
* Research:
* Epidemiology: to determine the incidence, prevalence, and distribution of different bone marrow failure syndromes at the national level;
* Biology: to better understand the pathophysiology of BMF; to identify and to study complications within each entity, such as mechanisms underlying clonal evolution, new forms of inherited BMF and acute myeloid leukemia (AML)/MDS-predisposition syndromes, and to better and deeper characterize known entities;
* Treatment: to identify prognostic factors and predictors of response; to identify side effects and impact of treatment on others organs and natural functions; to assess patients' quality of life as early as possible since diagnosis and throughout follow-up.
Conditions
- Bone Marrow Failure Syndrome
Interventions
- OTHER
-
Bone Marrow Failure
without interventional intervention . biological collection in the routine care Standard of care of patients with bone marrow failure.
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-02-06
- Primary Completion
- 2027-02-06
- Completion
- 2027-02-06
Countries
- France
Study Locations
More Related Trials
-
Discarded Bone Marrow for Hematology Research
NCT04671212 ·Status: RECRUITING
-
Survival in Myelofibrosis Patients After Allogeneic Hematopoietic Stem Cell Transplantation in Five Centers in France
NCT04282421 ·Status: COMPLETED
-
Collection of Samples and Data for the National Marrow Donor Program Repository
NCT00495300 ·Status: COMPLETED
-
Spanish Registry of Erythropoietic Stimulating Agents Study
NCT01739452 ·Status: COMPLETED
-
Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes
NCT06361641 ·Status: RECRUITING ·Phase: NA
-
National Marrow Donor Program Long-Term Donor Follow-Up
NCT01362179 ·Status: COMPLETED
-
A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers
NCT02409121 ·Status: COMPLETED ·Phase: NA
-
Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202)
NCT01879072 ·Status: COMPLETED
-
Retention of Bone Marrow Donors in a National Registry
NCT00005556 ·Status: COMPLETED
-
Diagnostic Value of Bone Marrow Tryptase in Systemic Mastocytosis
NCT02441166 ·Status: COMPLETED ·Phase: NA
-
Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
NCT04528355 ·Status: RECRUITING
-
Evaluation of Healthy Volunteer Marrow Donors Participating in the National Marrow Donor Program (NMDP)
NCT00001451 ·Status: COMPLETED
-
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
NCT03128996 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Prospective Study of Belated Pulmonary Complications Occurring in Children Treated With Allogeneic Hematopoietic Stem Cells.
NCT02032381 ·Status: COMPLETED ·Phase: NA
-
Pulmonary Complications of Allografts
NCT01219972 ·Status: COMPLETED
-
Cord Blood Transplantation in Patients With Advanced Lymphoid Malignancies
NCT01966510 ·Status: COMPLETED ·Phase: PHASE2
-
Protocol to Obtain Bone Marrow for Research
NCT00951925 ·Status: COMPLETED
-
Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation
NCT00737516 ·Status: COMPLETED ·Phase: PHASE2
-
Collection of Blood and Bone Marrow From Healthy Volunteers and Patients for Research Purposes
NCT00001627 ·Status: COMPLETED
-
Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
NCT01177527 ·Status: ACTIVE_NOT_RECRUITING
-
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
NCT02934477 ·Status: RECRUITING
-
Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx Study)
NCT05196789 ·Status: RECRUITING
-
Institut Paoli Calmettes Myelodysplastic Syndromes Database
NCT03275480 ·Status: RECRUITING
-
Screening for Subjects to Participate in Studies of Blood Disorders
NCT00695123 ·Status: COMPLETED
-
Studyof Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor in Elderly Patients
NCT02623309 ·Status: COMPLETED ·Phase: PHASE3